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Abstract
Background: Tuberculosis (TB) control remains a challenge in Malawi despite the National TB Control Program
since 1984. This study aimed at measuring patient and health system delays and identifying factors associated with
these delays.
Methods: A cross-sectional survey of 588 pulmonary TB patients was conducted in three TB centres in Blantyre,
Lilongwe, and Mzuzu, between July and December 2011 using a semi-structured questionnaire. Patient delay was
defined as the time interval between the onset of TB symptom(s) (a common symptom being coughing) to the first
visit to any health provider. Health system delay was the interval from the first care-seeking visit at any health
provider to the initiation of anti-tuberculosis treatment. Participants were invited to participate in the study during
intensive phase of treatment. The characteristics associated with patient and health system delays were analyzed.
Results: The median patient delay was 14 days for both new and retreatment TB cases (interquartile range [IQR] 14
– 28 and 7 – 21, respectively). The median health system delay was 59 days (IQR 26 – 108) for new and 40.5 days
(IQR 21–90) for retreatment cases. Factors associated with longer patient delay in new cases included primary
education (adjusted odds ratio [AOR] 2.2, 95% CI 1.3 – 3.9) and knowledge that more than three weeks of coughing
is a sign of TB (AOR 1.9, 1.1 – 3.3). In retreatment cases, distance >10 Km (AOR 3.3, 1.1 – 9.6) and knowledge that
more than three weeks of coughing is a sign of TB (AOR 3.7, 1.3 – 10.7; p < 0.05) were significant factors. Making
the first visit to a health centre (OR 1.9, 0.9 – 3.8) or a drug store/ traditional healer (OR 5.1, 1.1 – 21.7) in new TB
cases were associated with a longer health system delay (p < 0.05) while smear negative (OR 6.4, 1.5 – 28.3), and
smear unknown or not done (OR 6.1, 1.3 – 26.9) among retreatment cases were associated with a longer health
system delay (p < 0.05).
Conclusions: Effective management and new diagnostic techniques are needed especially among retreatment
cases. It is also needed to address geographic barriers to accessing care and increasing TB awareness in the
community.
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Background
Tuberculosis (TB) remains a major health problem des-
pite an increase in coverage of Directly Observed
Treatment Short Course (DOTS) therapy and adoption
of passive case detection globally. The goal of TB con-
trol is to reduce morbidity, mortality, transmission and
development of drug resistance. TB control remains a
major challenge in Malawi and the sub-Saharan region,
which bears the biggest impact of HIV fuelled TB epi-
demics [1,2]. In Malawi, a total of 21, 092 TB cases
were reported in 2010 with a notification rate of 142
per 100, 000 population. The estimated incidence of TB
was 219 per 100, 000 population and the estimated case
detection rate was 65%. The proportion of TB cases
tested positive for HIV was 70% in 2010 [3].
Malawi had operated a vertical TB control program
since 1984 and successfully implemented the DOTS strat-
egy [4]. Smear microscopy was performed at referral and
district hospitals and a few selected private and not-for-
profit mission hospitals with microscopes. Treatment has
been decentralized to rural health facilities [5]. During the
study period, Malawi had an estimated population of
14,000,000 with a total of 213 microscopy centres and 88
initiation centres where patients could be diagnosed, reg-
istered and started on anti-tuberculosis treatment [4,6].
Sputum microscopy is the primary investigative method
(gold standard) when suspecting TB in patients in Malawi.
Early case detection, prompt diagnosis and treatment
of TB are essential for an effective TB control program.
Despite services and medicines being given free of
charge to TB patients and control strategies being in
place for over two decades in Malawi, the estimated case
detection rate of TB remained relatively low, likely indi-
cating under-diagnosis as well as delays in the diagnosis
and treatment of TB [3]. These may result in increased
costs and disease severity in the individuals, as well as
increased morbidity and mortality of TB in the commu-
nity from increased risk of transmission of TB [7].
This study aims to measure the extent of and factors
associated with patient delay in seeking health care, as
well as health system delay in the diagnosis and treat-
ment of new and retreatment TB cases in Malawi. An
understanding of the main determinants of these delays
is essential for formulating effective policies for TB con-
trol. Although studies on delays in TB diagnosis have
been done before in Malawi [8,9], they only focused on
new cases and none have been performed among new
and retreatment TB cases simultaneously.
Methods
Study setting
A hospital based cross-sectional study was conducted at
three main TB registration centres out of a total of 213
microscopy centres and 88 initiation centres where
patients could be diagnosed, registered and started on
anti-tuberculosis treatment between July and December
2011. A registration centre was chosen in Blantyre,
Lilongwe and Mzuzu, representing the southern, central
and northern regions of Malawi, respectively. These cen-
tres are located within the three major cities to provide
services to a large number of TB cases, including referral
cases. Passive case finding and sputum microscopy were
the primary strategies used in the country during the
study period.
Study participants
The study population was composed of all registered
pulmonary TB patients (new and retreatment cases),
both male and female aged 15 years old or more, who
were receiving the intensive phase of treatment at the fa-
cilities during the study period. In this study, new TB
cases were patients who never had anti-TB treatment or
who had taken anti-TB drugs for less than one month.
Retreatment TB cases were patients who had previously
been treated for TB for one month or more. The eligible
patients who had consented to the interview were con-
secutively enrolled in the study during the time they
were receiving the intensive phase of treatment at the fa-
cilities during the study period. Patients with chronic
pulmonary TB, or those classified as treatment failure
TB cases, or mentally or terminally ill were excluded.
Data collection
Face-to-face interviews using a pretested questionnaire
were employed to collect data in this study. Three nurses
who had more than 5 years of experience in the manage-
ment of TB patients under the National TB Program
(NTP) in Malawi were trained to conduct the interview.
Patients were asked to provide information concerning
their demographic and socio-economic characteristics,
knowledge of TB, duration of symptoms before seeking
medical consultation and knowledge of the diagnosis and
treatment process. The patient’s health passport, TB treat-
ment card/ sheet and TB registers were evaluated where
appropriate to verify the responses.
Definition of delay
Patient delay was defined as the time interval between
the onset of TB symptom(s) (a common symptom being
coughing) to the first visit to any health provider. Health
system delay was the interval from the first care-seeking
visit at any health provider to the initiation of anti-
tuberculosis treatment. Total delay was the time interval
from the onset of symptoms to the initiation of anti-
tuberculosis treatment.
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Data management and analysis
Data analysis was performed using IBM’s SPSS Version
19 for Microsoft Windows. The distributions of both de-
lays were skewed and therefore non-parametric Kruskal
Wallis one-way analysis of variance was employed to
analyze associations between determinants and delays.
Further, the median patient delay of two weeks was
used to dichotomize patient delay into acceptable
(shorter) or longer delay. For the median health system
delay a two week period was used to dichotomize
shorter and longer health system delay as was recom-
mended by Malawi NTP [4]. Multiple logistic regression
analysis was used to analyze factors associated with lon-
ger patient and health system delays. p-values < 0.05
were considered statistically significant.
Ethical consideration
Ethical permission to conduct the study was obtained
from the National Health Sciences Research Committee
(NHSRC) of Malawi. The objective of the study was ex-
plained in detail to study subjects and verbal consent was
obtained from each individual before conducting the
interview.
Results
Sociodemographic characteristics of pulmonary TB
patients
A total of 588 pulmonary TB patients from three regis-
tration centres (Blantyre, Lilongwe and Mzuzu) receiving
the intensive phase of TB treatment were consecutively
enrolled in the study between July and December 2011.
Table 1 shows the characteristics of pulmonary TB pa-
tients enrolled in this study. There were 460 (78.2%)
new cases and 128 (21.8%) retreatment cases. After no-
ticing symptoms, the most common health facility first
visited by the patients was hospital (58.7%), followed by
health centre (22.6%), drug store (8.8%), private clinic
(7.7%), and traditional healer (2.2%). Of the 588 pulmon-
ary TB patients, 389 (66.2%) were smear positive, 58
(9.9%) were smear negative, and 141 (24.0%) were smear
result unknown or not done.
Patient delay and health system delay
The median patient delay was 14 days for both new and
retreatment TB patients (interquartile range [IQR] 14 –
28 and 7 – 21, respectively). In new cases, occupation
status (p = 0.017) was significantly associated with pa-
tient delay: the unemployed (median 21 days) and self-
employed (median 17.5 days) had longer patient delays
than those employed (median 14 days). Among patients
who had heard of TB before diagnosis, knowledge that
more than 3 weeks of coughing is a symptom of TB was
significantly associated with patient delay in both new
Table 1 Characteristics of pulmonary tuberculosis
patients in Malawi, 2011








Age at diagnosis (years)
15 – 24 86 (14.6)
25 – 34 211 (35.9)
35 – 44 161 (27.4)
45 – 54 69 (11.7)
55 – 64 40 (6.8)
65 + 21 (3.6)
Education











Average household monthly income (USD)
≤ 30 105 (17.9)
> 30 ≤ 60 119 (20.2)
> 60 171 (29.1)
Unknown 193 (32.8)
Distance to the nearest TB
diagnostic facility
0 – 10 Km 364 (61.9)
11 – 20 Km 99 (16.8)
>20 Km 71 (12.1)
Unknown 54 (9.2)
Heard of TB before diagnosis
Yes 396 (67.3)
No 192 (32.7)
Knowledge of coughing > 3 weeks
as a TB symptoma
Yes 268 (71.8)
No 105 (28.2)
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(p = 0.007) and retreatment cases (p = 0.018) (Tables 2
and 3).
The proportion of new TB patients with patient delay
longer than 2 weeks was 45% and that of retreatment
cases was 32.8% (p = 0.015) while the proportion of new
TB patients with health system delay longer than 2 weeks
was 47.8% and that of retreatment cases was 50.8% (p =
0.031). Among new cases, primary education (adjusted
odds ratio [AOR] 2.2, 95% CI 1.3 – 3.9) and knowledge
that more than 3 weeks of coughing is a symptom of TB
(AOR 1.9, 95% CI 1.1 – 3.3) were both significantly associ-
ated with longer patient delay (Table 4) when compared
with other groups. For retreatment cases, knowledge that
more than 3 weeks of coughing is a symptom of TB (AOR
3.7, 95% CI 1.3 – 10.7) and living at distances greater than
10 Kilometres (Km) from the nearest TB diagnostic facility
(AOR 3.3, 95% CI 1.1 – 9.6) were significantly associated
with longer patient delay when compared with other
groups (Table 4). A cumulative 50.2% of new TB pa-
tients and 60.2% of retreatment cases had made visits
to a health provider within 2 weeks after the onset of
symptoms.
The median health system delay was 59 days (IQR 26–
108) for the new cases, which was longer than retreatment
cases (40.5 days [IQR 21 – 90]) (p = 0.031). In new TB
cases, the type of health facility first visited (p < 0.001) was
significantly associated with health system delay (Table 2).
For retreatment cases, the type of health facility first vis-
ited (p = 0.002) and smear results (p = 0.024) were signifi-
cantly associated with health system delay (Table 3).
Further, using a period of 2 weeks to dichotomize
health system delay into shorter and longer health
system delay [10], making the first visit to a health
centre (OR 1.9, 95% CI 0.9 – 3.8), or a drug store or a
traditional healer (OR 5.1, 95% CI 1.1– 21.7) were
significantly associated with longer health system delays
among new TB cases as compared to visiting a hospital.
For retreatment cases, smear negative (OR 6.4, 95% CI
1.5 – 28.3) and smear unknown or not done (OR 6.1,
95% CI 1.3 – 26.9) results were significantly associated
with longer health system delay (Table 5). For health
system delay, only a cumulative 14.5% of the patients
had been started on treatment after two weeks from the
first visit to health providers, including 13.5% for new
cases and 18.0% fir retreatment cases.
Total delay
The median total delay was 80 days (IQR 44–129). New
cases had a longer median (85.5 days) total delay as
compared with retreatment cases (60.5 days) (p = 0.002).
The health system delay contributed more than 70% to
the total delay. After a period of 4 weeks since the onset
of symptoms only a cumulative 9.7% of the patients had
been started on anti-tuberculosis treatment, with 9.1%
for new cases and 11.7% for retreatment cases.
Discussion
This study reveals that there were substantial delays be-
tween the onset of reported symptoms and the initiation
of anti-tuberculosis treatment among pulmonary TB
cases in Malawi with these delays mainly related to the
health care system. The median health system delay in
both new (59 days) and retreatment (40.5 days) TB cases
are longer than patient delay (14 days) for both types of
TB cases. A large proportion of patients (90%) had not
been started on anti-tuberculosis treatment 4 weeks after
the onset of presenting symptoms, and coughing being
the most common symptom (89%) of these cases.
Patient delay
The median patient delay (14 days) was found to be
within the recommended target of 2 weeks and was
shorter than median health system delays (59 days and
40.5 days for new and retreatment cases, respectively)
[10]. Delays in the diagnosis and treatment of pulmonary
TB have been shown to be associated with an increased
risk of infectivity and poor clinical outcomes [11].
The median patient delay in this study for new cases
was shorter than that found in earlier studies conducted
in Malawi in 2000 (56 days) and 2008 (33.5 days); there
were however no previous studies on retreatment cases
for comparison [8,9]. The marked reduction in patient
delay could be attributed to increased community aware-
ness, increased access to diagnostic services and im-
proved treatment outcomes following decentralization of
TB services [4,12]. The median patient delay was also
shorter than that in Ethiopia and Tanzania (30 days)
[13,14], but longer than that in Taiwan (7 days) [15].
Table 1 Characteristics of pulmonary tuberculosis
patients in Malawi, 2011 (Continued)
Health facility first visited
Hospital 345 (58.7)
Health centre 133 (22.6)
Drug store 52 (8.8)
Private clinic 45 (7.7)
Traditional healer 13 (2.2)
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In this study, education was found to be significantly
associated with patient delay in new cases, where those
with only primary education had longer patient delay
than those with secondary education. Not attending
school and illiteracy were factors significantly associated
with patient delay in studies in Gambia and seven
Table 2 Patient and health system delay among new TB cases, by background characteristics, Malawi, 2011
Patient delay (days) Health system delay (days)
n Median IQR Median IQR
Total 460 14.0 14-28 59.0 27-108
Sex
Male 304 14.0 14-28 59.0 28-99
Female 156 21.0 14-30 64.0 24-125
Age at diagnosis (years)
< 34 221 21.0 14-30 59.0 27-100
≥ 34 239 14.0 14-28 63.0 26-121
Education
No school 65 21.0 14-30 84.0 41-152
Primary 219 21.0 14-28 57.0 27-107
Secondary & above 176 14.0 7-28 54.0 24-91
Occupation
Unemployed 204 21.0 14-30 * 66.5 31-118
Self-employed 146 17.5 14-30 * 51.5 24-92
Employed 110 14.0 7-21 * 62.0 28-121
Distance to nearest TB diagnostic facility
0 – 10 Km 278 21.0 14-28 56.5 26-100
>10 Km 140 21.0 14-28 73.5 32-119
Unknown 42 14.0 13-28 47.5 21-133
Heard of TB before diagnosis
Yes 268 14.0 14-28 66.0 31-116
No 192 21.0 14-28 50.5 22-98
Knowledge of coughing > 3 weeks
as a TB symptom
Yes 186 21.0 14-30 * 73.0 29-116
No 82 14.0 7-28 * 64.0 31-118
Perceiving condition as worsening
Yes 80 14.0 14-30 39.5 19-93
No 380 17.5 14-28 63.0 31-115
Health facility first visited
Hospital 253 14.0 14-28 45.0 20-86 *
Health centre 114 21.0 14-30 86.0 43-135 *
Drug store& traditional 53 14.0 11-21 91.0 54-140 *
Private clinic 40 21.0 14-30 57.0 27-94 *
Smear
Positive 302 14.0 14-28 62.5 28-111
Negative 37 21.0 7-29 66.0 26-127
Unknown/not done 121 21.0 14-29 56.0 25-98
Note: Using nonparametric Kruskal Wallis test, IQR = interquartile range.
* p < 0.05.
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Table 3 Patient delay and health system delay among retreatment TB cases, by background characteristics,
Malawi, 2011
Patient delay (days) Health system delay (days)
n Median IQR Median IQR
Total 128 14.0 7-21 40.5 22-91
Sex
Male 84 14.0 7-25 40.5 21-98
Female 44 14.0 7-21 41.0 22-84
Age at diagnosis (years)
< 34 55 14.0 7-21 43.0 24-93
≥ 34 73 14.0 7-28 39.0 21-88
Education
No school 17 14.0 14-28 62.0 21-95
Primary 66 14.0 7-29 40.5 22-93
Secondary & above 45 14.0 7-21 40.0 21-83
Occupation
Unemployed 51 14.0 7-28 43.0 27-82
Self-employed 55 14.0 7-21 39.0 19-113
Employed 22 14.0 7-21 39.5 19-104
Distance to nearest TB diagnostic facility
0 – 10 Km 86 14.0 7-21 47.5 23-95
>10 Km 30 21.0 14-28 25.5 17-54
Unknown 12 17.5 9-30 74.0 42-102
Heard of TB before diagnosis
Yes 128 14.0 7-21 40.5 22-91
No 0 - - - -
Knowledge of coughing > 3 weeks
as a TB symptom
Yes 82 21.0 14-30 * 40.0 22-92
No 23 14.0 7-28 * 41.5 20-107
Perceiving condition as worsening
Yes 23 14.0 7-28 41.0 19-73
No 105 14.0 7-21 40.0 22-93
Health facility first visited
Hospital 92 14.0 7-21 38.0 22-71 *
Health centre 19 21.0 14-30 43.0 17-130 *
Drug store& traditional 12 14.0 14-28 123.5 85-189 *
Private clinic 5 7.0 7-14 76.0 18-133 *
Smear
Positive 87 14.0 7-28 38.0 16-79 *
Negative 21 14.0 7-25 59.0 30-162 *
Unknown/ not done 20 14.0 7-20 68.5 28-97 *
Note: Using nonparametric Kruskal Wallis test, IQR = interquartile range.
* p < 0.05.
Makwakwa et al. BMC Infectious Diseases 2014, 14:132 Page 6 of 9
http://www.biomedcentral.com/1471-2334/14/132
countries of the Eastern Mediterranean Region [16,17].
However in this study, the no-school group was not sig-
nificantly associated with patient delay. Nevertheless, pa-
tients with higher education likely had more opportunity
to obtain information about TB.
In both new and retreatment cases, there was a signifi-
cant association between patient delay and knowledge
that more than 3 weeks of coughing is a symptom of
TB. Those patients who knew that coughing for more
than 3 weeks is a TB symptom were more likely to have
longer delay. This is contradictory to common belief that
knowledge of TB may trigger action of seeking health
care. We therefore speculate that this may have hap-
pened either because the patients did not believe TB
Table 4 Logistic regression analysis of determinants of longer patient delay, Malawi, 2011
Characteristic New TB cases Retreatment TB cases
n Unadjusted OR Adjusted OR n Unadjusted OR Adjusted OR
(95% CI) (95% CI) (95% CI) (95% CI)
Total 460 128
Education
No school 65 1.47 (0.83 – 2.60) 1.73 (0.67 – 4.44) 17 1.27 (0.41 – 3.98)
Primary 219 1.42 (0.95 – 2.11) 2.22 (1.25 - 3.94)* 66 1.34 (0.61 – 2.92)
Secondary & above 176 reference 45 reference
Occupation
Unemployed 204 reference 51 reference
Self-employed 146 0.86 (0.56 – 1.31) 55 0.95 (0.44 – 2.07)
Employed 110 0.61 (0.39 – 0.98) 22 0.82 (0.29 – 2.29)
Knowledge of coughing > 3 weeks as a TB symptom
Yes 186 1.88 (1.11 – 3.19) 1.90 (1.10 –3.30)* 82 2.56 (0.99 – 6.61) 3.65 (1.25 –10.69)*
No 82 reference 23 reference
Distance to nearest TB diagnostic facility
0 – 10 Km 278 reference 86 reference
> 10 Km 140 1.04 (0.69 – 1.57) 30 2.25 (0.97 – 5.23) 3.31 (1.14 – 9.59)*
Unknown 42 0.67 (0.35 – 1.30) 12 1.97 (0.58 – 6.64) 2.02 (0.38 – 10.76)
Perceiving condition as worsening
Yes 80 0.95 (0.59 – 1.54) 23 0.96 (0.38 – 2.43)
No 380 reference 105 reference
OR = odds ratio, CI = confidence interval.
*p < 0.05.
Table 5 Logistic regression analysis of determinants of longer health system delay, Malawi, 2011
Characteristic New TB cases Retreatment TB cases
n Unadjusted OR (95% CI) n Unadjusted OR (95% CI)
Total 460 128
Place first visited by patients
Hospital 253 reference 92 reference
Health centre 114 1.86 (1.92 – 3.77)* 19 0.91 (0.27 – 3.08)
Drug store & traditional 53 5.08 (1.08 -21.67)* 12 - ±
Private clinic 40 0.94 (0.39 – 2.26) 5 0.97 (0.10 – 9.24)
Smear
Positive 302 reference 87 reference
Negative 37 0.65 (0.27 – 1.59) 21 6.36 (1.54 – 28.31)*
Unknown/not done 121 1.08 (0.57 – 2.04) 20 6.05 (1.26 – 26.91)*
OR = odds ratio, CI = confidence interval.
*p < 0.05.
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could happen to them, or they were waiting for the
3 week period to elapse before seeking care. They may
also have feared being stigmatized, especially in Malawi
where there is strong association between HIV/AIDS
and TB in the face of high HIV/AIDS and TB co-
infection rate (70%).
In retreatment cases, living at distances longer than 10
Km from a TB diagnostic facility was significantly associ-
ated with longer patient delays. This was in-line with the
finding in the previous study in Malawi and therefore
likely reveals barriers to accessing care among patients
living in the suburbs and distant areas, thereby increas-
ing the risk of transmission of TB [8]. An increase in TB
diagnostic facilities and mobile clinics or sputum collec-
tion centres close to the communities might be an im-
portant step; that is, to decentralizing the services
towards peripheral to enhance their diagnosis capacity
and to reduce delays. Further innovative methods in case
finding in the community should be considered to in-
crease access to health services among those who have
limited access to health care and close contacts to
known TB patients [18].
Health system delay
The alertness of the health system to the diagnosis and
treatment of TB is essential to the control of TB in
Malawi [19]. There were no previous studies done in
Malawi that specified the health system delay period for
comparison with the findings in this study. Nevertheless,
the median health system delay (59 days for new cases
and 40.5 days for retreatment cases) in this study was
well beyond the recommended 2-weeks period for an ef-
fective health system to control TB [4,10]. As compared
to the patient delay, the median health system delay was
significantly longer and contributed a higher percentage
(over 70%) to the total delay.
The type of health facility first visited by the patients
was significantly associated with health system delay
among new cases. Significant delays were especially
among patients who made the first visits to a health
centre and a drug store or a traditional healer. Long
pathways to TB diagnosis including multiple patient
visits to health centres and traditional healers, prescrib-
ing an antibiotic, and health system structural barriers
were some of the findings causing delays to diagnosis of
pulmonary TB in previous studies in Malawi [8,20-22].
This may have also resulted from hospitals generally
having more qualified staff and more equipment, such as
microscopes, than health centres. It is essential to
sensitize drug stores and traditional healers and enhance
the capacity of health centres to ensure prompt referral,
diagnosis and treatment of TB.
During the study, sputum microscopy was the primary
investigative method when suspecting TB as GeneXpert
had not yet been piloted in the country. It was however
noticed that in a quarter of the patients, results of spu-
tum smears were not available at the initiation of treat-
ment. We were not able to determine whether this was
due to patients’ inability to produce sputum (dry cough),
inconclusive smear microscopy results, or clinicians’
over reliance on chest X-rays. Nevertheless, subsequent
smear examination results among these patients indi-
cated that they were smear negative.
Similar to that among new TB patients, negative smear
results and smear unknown or not done were signifi-
cantly associated with longer health system delay among
retreatment TB cases in this study. Significant delays be-
tween sputum examination and starting TB treatment
among smear negative patients have been documented
in an earlier study in Malawi, which ranged from 3 to
6 weeks [23]. The reasons for the delays in this previous
study were assessing the outcomes of antibiotic treat-
ment and arranging for a chest X-ray examination. Clini-
cians’ difficulties in making a diagnosis among smear
negative TB patients who had submitted multiple sets of
sputum samples and received more than two courses of
antibiotics before starting TB treatment were noted in a
previous study in Malawi [22]. Smear negative pulmon-
ary TB therefore still remains a clinical problem in
Malawi coupled with the high prevalence of HIV/TB co-
infection and limited resources which may promote fur-
ther disease progression and transmission [22,24,25].
Close monitoring of smear negative patients, effective
management algorithms, and new (fast) diagnostic tech-
niques tailored for a resource-poor setting to comple-
ment sputum microscopy are required to control delays
among smear negative TB patients.
The study nevertheless had limitations. First, the study
depended on the patient’s ability to recall their health-
seeking period, which is subject to recall bias. The study
did not measure the effect of TB and HIV/AIDS co-
infection, which may have had major effects on the de-
lays [26]. Lastly, this study was performed in the TB
diagnostic facilities located in the cities where there is
better access to services and therefore the extent of de-
lays, and factors affecting the delays may be different
from those in rural areas. Consequently this study pro-
vides estimates of delays in urban areas, which are con-
sidered to have better access to TB services and perhaps
a higher risk of infection.
Conclusion
This study reveals substantial delays in the diagnosis and
treatment of pulmonary TB in Malawi, noting health
care system delays being longer than patient delays.
Smear negative results among retreatment cases were
associated with longer health system delay. To reduce
health system delays, effective management algorithms
Makwakwa et al. BMC Infectious Diseases 2014, 14:132 Page 8 of 9
http://www.biomedcentral.com/1471-2334/14/132
and new diagnostic techniques to complement sputum
microscopy are required among smear negative patients
including retreatment cases. In addition, there is need to
sensitize drug stores and traditional healers for prompt re-
ferral. Peripheral diagnosis strategy should be employed in
Malawi through expanding and enhancing the capacity of
existing health centres. This would also address geo-
graphic barriers to accessing care complemented by in-
creased TB awareness in the communities.
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